Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Aripiprazole
Active Ingredient: Aripiprazole 2mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Apo-Aripiprazole
Active Ingredient: Aripiprazole 5mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Apo-Aripiprazole
Active Ingredient: Aripiprazole 10mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Apo-Aripiprazole
Active Ingredient: Aripiprazole 15mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Apo-Aripiprazole
Active Ingredient: Aripiprazole 20mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Apo-Aripiprazole
Active Ingredient: Aripiprazole 30mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Avage
Active Ingredient: Tazarotene 1mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Texas, United States of America
Product: Strepfen Intensive Instants
Active Ingredient: Flurbiprofen 8.75mg
Dosage Form: Oral granules
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare International Limited, Nottingham, United Kingdom
Product: Zorac
Active Ingredient: Tazarotene 0.5mg/g
Dosage Form: Topical gel
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Texas, United States of America
Product: Zorac
Active Ingredient: Tazarotene 1mg/g
Dosage Form: Topical gel
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Texas, United States of America
Product: Zorac
Active Ingredient: Tazarotene 0.5mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Texas, United States of America
Product: Zorac
Active Ingredient: Tazarotene 1mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Sales LLC, Texas, United States of America
Dated this 28th day of February 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).